Skip to main content

Want a detailed portfolio tracker?

Roivant Sciences (ROIV) P/E (2021 - 2026)

Roivant Sciences (ROIV) P/E from Oct 1, 2021 to Jun 3, 2026. The TTM Roivant Sciences (ROIV) P/E is -64.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Roivant Sciences (ROIV)

YearP/EChange
2026-64.35+244.96%
2025-18.65-78.42%
2024-86.42+891.94%
2023-8.71+83.94%
2022-4.74+58.49%
2021-2.99N/A

Comparison Roivant Sciences (ROIV) P/E with competitors

Roivant Sciences (ROIV) P/E is -64.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.10-100.16%
ENLVEnlivex Therapeutics Ltd0.15-100.23%
FGENFibroGen Inc0.24-100.37%
TRAWTraws Pharma Inc0.47-100.73%
FBIOFortress Biotech Inc0.71-101.10%
CHRSCoherus Biosciences Inc0.98-101.52%
ORMPOramed Pharmaceuticals Inc1.47-102.29%
AGENAgenus Inc2.05-103.18%
VIVSVivoSim Labs Inc2.54-103.94%
INVAInnoviva Inc3.19-104.96%
CRMDCorMedix Inc3.65-105.67%
ABEOAbeona Therapeutics Inc4.20-106.53%
VXRTVaxart Inc4.26-106.62%
CVACCureVac N.V.4.45-106.91%
SRPTSarepta Therapeutics Inc4.62-107.19%
GLPGGalapagos NV4.86-107.55%
RIGLRigel Pharmaceuticals4.92-107.65%
ZVRAZevra Therapeutics Inc4.97-107.73%
ABUSArbutus Biopharma Corp5.69-108.85%
CGENCompugen Ltd7.38-111.47%
AUPHAurinia Pharmaceuticals Inc9.25-114.38%
ACADAcadia Pharmaceuticals Inc9.59-114.90%
OMEROmeros Corporation9.88-115.36%
PLXProtalix BioTherapeutics Inc9.91-115.40%
SPROSpero Therapeutics Inc10.73-116.68%
ADMAAdma Biologics Inc11.33-117.61%
SVASinovac Biotech Ltd11.44-117.77%
TBPHTheravance Biopharma Inc11.78-118.30%
HRMYHarmony Biosciences Holdings Inc12.18-118.93%
TGTXTG Therapeutics Inc13.18-120.48%
INCYIncyte Corp13.38-120.80%
SABSSAB Biotherapeutics Inc14.06-121.85%
XOMAXOMA Corp14.95-123.23%
REGNRegeneron Pharmaceuticals Inc14.98-123.28%
PBYIPuma Biotechnology Inc15.05-123.39%
EXELExelixis Inc15.79-124.55%
NAGENiagen Bioscience Inc16.35-125.42%
CPRXCatalyst Pharmaceuticals Inc17.34-126.95%
MDXGMimedx Group Inc17.38-127.00%
ARGXArgen X SE23.07-135.85%
HALOHalozyme Therapeutics Inc23.20-136.06%
XOMAOXOMA Corp25.34-139.39%
VRTXVertex Pharmaceuticals Inc25.66-139.87%
XOMAPXOMA Corp25.67-139.89%
CTMXCytomX Therapeutics Inc25.70-139.94%
ASNDAscendis Pharma A/S26.35-140.96%
RPRXRoyalty Pharma plc - Class A27.50-142.73%
SLNOSoleno Therapeutics Inc29.02-145.09%
LGNDLigand Pharmaceuticals Inc - Class B30.19-146.91%
BMRNBiomarin Pharmaceutical Inc37.51-158.29%
APLSApellis Pharmaceuticals Inc39.02-160.64%
KRYSKrystal Biotech Inc39.70-161.69%
GMABGenmab40.20-162.48%
ONCBeiGene Ltd67.03-204.16%
TECHBio-Techne Corp68.59-206.60%
VCELVericel Corp80.63-225.30%
PHARPharming Group N.V.87.74-236.35%
ALNYAlnylam Pharmaceuticals Inc124.93-294.16%
TLXTelix Pharmaceuticals Ltd139.89-317.40%
CORTCorcept Therapeutics Inc158.39-346.15%